Press-release for stocks for eli lilly and company

entities : Eli lilly and company crawled time : 13:20

save search

COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
Published: 2023-07-19 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 66.39% | O: 0.04% H: 0.8% C: 0.48%
RUBY | $0.057 -99.3% 760K

Health Technology

| 160.56% | O: 7.98% H: 0.0% C: 0.0%
GBIO | $2.81 1.08% 1.07% 250K

Health Technology

| -42.91% | O: -0.19% H: 9.21% C: -1.73%
pharmaceuticals

Verastem Oncology Appoints Karin Tollefson, PhD, to Board of Directors
Published: 2023-05-16 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 72.79% | O: -0.07% H: 0.98% C: 0.56%
VSTM | $9.86 -3.62% -3.75% 150K

Health Technology

| 103.36% | O: 2.81% H: 0.0% C: -1.86%
SGEN | $228.74 0.1% 20M

Health Technology

| 14.63% | O: -4.9% H: 0.74% C: -1.13%

Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer
Published: 2023-05-09 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 73.5% | O: -0.22% H: 0.89% C: -0.79%
therapeutics

Nektar Therapeutics Announces It Will Regain Full Rights to Rezpegaldesleukin (REZPEG, NKTR-358), a Novel, First-in-Class Selective Regulatory T-cell (Treg) Therapy in Clinical Development
Published: 2023-04-27 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 99.53% | O: 3.98% H: 1.86% C: -0.23%
NKTR | $1.265 -4.17% -4.35% 4.7M

Health Technology

| 68.62% | O: 0.26% H: 1.82% C: -2.21%
nktr-358 t-cell therapeutics therapy

Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Published: 2023-04-11 (Crawled : 13:20) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 104.57% | O: 0.21% H: 0.28% C: -1.01%
america pharma growth

Curavit Clinical Research Appoints Jackie Kent to Board of Directors
Published: 2023-03-07 (Crawled : 13:20) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
research

AC Immune to Present at the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 119.16% | O: -2.5% H: 0.39% C: -0.99%
ACIU | $2.375 -0.21% -0.21% 320K

Health Technology

| -4.42% | O: -1.61% H: 2.45% C: 1.22%
biopharma global conference

HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-26 (Crawled : 13:20) - prnewswire.com
GILD | News | $66.77 0.92% 0.91% 11M

Health Technology

| Email alert Add to watchlist
NVO | $122.71 -0.03% 0.17% 5M

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| Email alert Add to watchlist
SYNH | $42.98 0.0% 7.4M

Health Services

| Email alert Add to watchlist
ICLR | $288.32 -1.2% -1.21% 640K

Health Technology

| Email alert Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| Email alert Add to watchlist
covid-19 trials research global report hiv impact study market

Outlook on the Non-steroidal Anti-inflammatory Drugs Global Market to 2028 - Featuring Pfizer, GlaxoSmithKline, Bayer and Teva Pharmaceutical Industries Among Others
Published: 2022-09-26 (Crawled : 13:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 39.13% | O: 4.62% H: 0.0% C: -4.87%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 26.36% | O: 5.77% H: 0.0% C: -2.27%
AZNCF | $138.24 -4.19% 800

Health Technology

| 24.88% | O: -1.15% H: 0.0% C: -2.43%
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -42.33% | O: -0.61% H: 1.19% C: 0.05%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 34.88% | O: -1.02% H: 0.72% C: -0.83%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 141.05% | O: -0.85% H: 0.95% C: -0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 18.58% | O: -2.29% H: 0.35% C: -0.67%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| 25.07% | O: -1.52% H: 0.48% C: -1.36%
global teva market

Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022
Published: 2022-09-21 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 148.82% | O: -0.24% H: 1.17% C: -1.5%
VERU | $1.305 -8.1% -8.81% 2.6M

Health Technology

| -88.04% | O: -0.84% H: 0.17% C: -9.05%
conference

New Synopsys Research Finds Significant Increase in Practices to Bolster Software Supply Chain Security
Published: 2022-09-21 (Crawled : 13:20) - prnewswire.com
SYF | $41.57 1.89% 0.0% 4.5M

Finance

| 25.41% | O: 0.79% H: 0.34% C: -3.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.26% | O: -0.12% H: 1.08% C: -1.05%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 148.82% | O: -0.24% H: 1.17% C: -1.5%
SNPS A | $510.65 -1.74% -1.77% 1.2M

Technology Services

| 66.82% | O: 0.95% H: 1.96% C: -1.93%
research security software

Qualigen Therapeutics Announces Formation and First Meeting of QN-302 Scientific Advisory Board
Published: 2022-08-18 (Crawled : 13:20) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -48.41% | O: 0.24% H: 0.26% C: -1.64%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 136.97% | O: -0.02% H: 0.7% C: -0.01%
BMO | $92.14 1.24% 0.0% 310K

Finance

| -12.62% | O: -0.15% H: 1.03% C: 0.68%
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -92.93% | O: 0.19% H: 0.94% C: -1.18%
qn-302 meeting therapeutics

Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Officer for Loxo@Lilly
Published: 2022-08-11 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 146.47% | O: -1.18% H: 1.46% C: 0.05%
commercial

Concarlo Therapeutics Hires Vadim Shepel as Chief Business & Operating Officer, Completing Build-out of Company's Core Executive Team
Published: 2022-07-27 (Crawled : 13:20) - biospace.com/
BNPQF | $68.558 -13.4% 400

Finance

| 48.71% | O: 0.0% H: 0.0% C: -5.21%
BNPQY | $34.61 -2.68% 100K

Finance and Insurance

| 52.83% | O: 0.67% H: 2.32% C: 2.18%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 126.44% | O: -0.78% H: 0.57% C: -0.01%
therapeutics

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests
Published: 2022-07-18 (Crawled : 13:20) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 126.41% | O: -0.45% H: 0.56% C: -2.53%
diagnostics

Ancora Heart Appoints Mark Miles as Chief Commercial Officer
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 152.93% | O: 4.14% H: 0.0% C: 0.0%
commercial heart miles

IconOVir Bio Appoints William Kaelin, Jr., M.D., to Board of Directors
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 152.93% | O: 4.14% H: 0.0% C: 0.0%